Vibar, Justina Q.
HRN: 23-84-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/03/2023
10/10/2023
IV
1.5g
Q6hrs
Abscess R Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes